The Brand Name LOPID Has Generic Salt :: Gemfibrozil 

LOPID  Is From Company PFIZER Priced :: Rs. N.I.

LOPID have Gemfibrozil is comes under Sub class Anti Hyperlipidemics of  Main Class Cardiovascular System

Main Medicine Class:: Cardiovascular System  Sub Medicine Class :: Anti Hyperlipidemics 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Gemfibrozil  TAB  Rs. N.I.  10
Brand Name Company / Manufacturers Strength Unit Price / 10
 LOPID  PFIZER  600MG  10 Rs. N.I.

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From PFIZER :: LOPID  Gemfibrozil  Cardiovascular System Anti Hyperlipidemics

Indications for Drugs ::

Hypertriglyceridemia, Hyperlipidemia

Drug Dose ::

Adult: PO 1.2 g/day in 2 divided doses. Maintenance: 0.9-1.5 g/day.

Contraindication ::

Hypersensitivity. Severe hepatic or renal dysfunction; gall stones; neonates, children, pregnancy, lactation.

Drug Precautions ::

Causes of secondary hyperlipidaemia such as hypothyroidism and diabetes must be treated before initiating therapy. Renal impairment; blood disorders. Periodic monitoring of the serum lipids should be done; if no adequate response after 3 mth, treatment should be withdrawn. May increase risk of cholelithiasis.

Drug Side Effects ::

Myositic syndrome, cholelithiasis, GI disturbances, rash, headache, blood dyscrasias, myalgia. Impotence, painful extremities, blurred vision; pruritus, urticaria; impotence; dizziness; cholestatic jaundice. Potentially Fatal: Bone marrow hypoplasia; intracranial haemorrhage; nephrotoxicity; peripheral neuritis.

Pregnancy category ::
Pregnancy category


Drug Mode of Action ::  

Gemfibrozil exhibits its action by inhibition of lipolysis and reduction of hepatic fatty acid uptake. It also inhibits secretion of VLDL from the liver.

Drug Interactions ::

Co-admin with repaglinide may increase serum levels of repaglinide. May enhance effects of oral anticoagulants. May also increase the plasma concentrations of ciclosporin and associated nephrotoxicity when used concurrently. Potentially Fatal: Increased risk of myopathy and rhabdomyolysis when used with HMG-CoA reductase inhibitors.


Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.


One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.